Recordings
MONDAY, JUNE 1
GENERAL SESSION: Research Year in Review |
R2 OCR Audits: Past, Present, and Future Considerations for Privacy and Security |
R3 Stop! Or Else I’ll Say Stop Again! Institutional Responses to COI Noncompliance |
R4 The Civil Monetary Penalties Law and the Role of HHS-OIG: Self-Disclosure and Enforcement |
R5 Managing Compliance as an NCI National Community Oncology Research Program NCORP Site? |
R6 The Pathway of Part 2 Data in Research: Opioids, Covered Entities, and IRBs, Oh My! |
R7 Responsible Conduct: Collaborating on RCR Training |
R8 Compliance and Culture: How Design and Approach Can Help Support Clinical Trial Billing |
R9 How to Overcome the Challenges of Effectively and Legally Implementing Research in a Skilled Nursing Facility |
GENERAL SESSION: Preventing Grant Fraud, Waste and Abuse |
TUESDAY, JUNE 2
GENERAL SESSION: Difficult Case Scenarios in Clinical Research Billing |
R13 CRRC: Clinical Research Revenue Cycle Management: Avoiding the Pitfalls |
R14 The Benefit of Collaboration between Compliance and Business Units: Enhancing Compliance at Your Institution |
R15 A Compliance Officer’s Research Data Nightmare and How to Wake Up From It |
R16 Right to Try Laws vs. FDA Expanded Access: What You Need to Know and What You Need to Do |
R17 Protecting Research Participants Financially: Making SENSE of Patient-CENTric Research When Patients Lack CENTS |
R18 In Unity Is Strength: Research Compliance Through Leadership |
R19 Dealing with Data: Nontechnical Thoughts Concerning Data Security and Management |
R20 When is it Research and When is it Not? The Special Cases of Quality Assurance Studies and Medical Device Improvement |
GENERAL SESSION: “Research Compliance During the Pandemic” – A Round Table |
WEDNESDAY, JUNE 3
R22 Conflict of Interest 101: Identifying, Managing, and Preventing Research Risk |
R23 Supplementing Traditional Research Compliance Monitoring and Auditing with Anticipatory Surveillance |
R24 The Laws of the Jungle: An Introduction to the Regulation of Animal Research |
R25 Research Stepchildren: Humanitarian Use Devices and Expanded Access to Investigational Medical Products |
R26 “Wish I Had Known That a Year Ago”: Lessons Learned in the Midst of Conducting a Research Misconduct Inquiry and Investigation |
R27 Let’s Talk About It: The Reality of the Impact of the Changes from the Revised Human Subject RulesRecording |
R28 Noncompliance in Animal Research Oversight |
R29 Demonstrating Good Clinical Practice (GCP) Compliance in Research through the maintenance of Regulatory Documents |